OPEN END TURBO LONG - HALEON Share Price

Certificat

DE000MD7LM24

Market Closed - Börse Stuttgart 07:22:02 31/05/2024 pm IST
0.75 EUR -1.32% Intraday chart for OPEN END TURBO LONG - HALEON
1 month-17.58%
3 months-14.77%
Date Price Change
31/24/31 0.75 -1.32%
30/24/30 0.76 +4.11%
29/24/29 0.73 -6.41%
28/24/28 0.78 -.--%
24/24/24 0.78 -9.30%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 07:22 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MD7LM2
ISINDE000MD7LM24
Date issued 30/08/2022
Strike 260.2 p
Maturity Unlimited
Parity 1 : 1
Emission price 0.44
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.33
Lowest since issue 0.152

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.251 GBP
Average target price
3.62 GBP
Spread / Average Target
+11.35%
Consensus